Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.

Autor: Esfandiar S; Biotechnology Group, Chemical Engineering Department, Tarbiat Modares University, P.O. Box 14115-143, Tehran, Iran., Hashemi-Najafabadi S, Shojaosadati SA, Sarrafzadeh SA, Pourpak Z
Jazyk: angličtina
Zdroj: Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2010 Apr 14; Vol. 55 (4), pp. 209-14. Date of Electronic Publication: 2010 Apr 14.
DOI: 10.1042/BA20090256
Abstrakt: The expression of rhIL-2 (recombinant human interleukin-2) in bacteria results in the formation of insoluble inclusion-body aggregates. These aggregates were first solubilized under denaturing conditions (sodium phosphate buffer solution containing 8 M urea and 10 mM 2-mercaptoethanol) and then purified using IMAC (immobilized metal-ion-affinity chromatography). IMAC was used to capture rhIL-2. The protein was gradually refolded on the column by a gradient elution (8 M to 0 M urea) in the presence of 10% (v/v) glycerol. Glycerol was used to prevent protein aggregation during the refolding step. Using this method, rhIL-2 was collected at 97% purity and its activity was measured by the lymphocyte transformation test. The measured activity was identical with commercial human interleukin-2.
Databáze: MEDLINE